The merger, they said, will help serve more people and grow their collective impact supporting those in need of home-based care.
As part of the deal, which is expected to close in November, VNAHG’s home health, hospice and physician service programs will be integrated into Bayada’s operations.
Dr. Steven Landers, CEO and president of VNAHG, will serve as group president, overseeing its home health and hospice specialties, including the operation of all hospital partnerships.
“By joining forces with VNA Health Group, we will expand access to quality care made possible through our operational and clinical expertise and help to improve patient outcomes for our strategic health systems partners,” Bayada CEO David Baiada said. “Dr. Landers is a proven leader in the home health care industry; the addition of his leadership, clinical excellence and innovative solutions will help us further propel our organization and build out our home health, hospice and physician services.”
VNAHG’s staff will join Bayada’s community of more than 28,000 caregivers across 360 locations in 23 states and internationally, they said.
“BAYADA’s long-standing commitment to delivering quality clinical care through their proven operational model and support systems, producing improved patient outcomes, is a strategic priority that the VNA Health Group and I share,” Landers said. “We are eager to join a team that will help us all make an even greater positive impact on the lives of more people who are in need of home health care.”
Also, VNA of Central Jersey Foundation, the foundation arm of VNAHG, will remain as an independent organization.
“Thanks to the growth of BAYADA’s home health and hospice specialties that our Home Health and Hospice Practice Presidents Mike Johnson and Adam Groff, respectively with their teams, have achieved, we have a unique strategic opportunity to serve more lives through partnerships with mission-aligned organizations like VNA Health Group,” Baiada said. “We look forward to blending the best of both business operations and clinical models, and together capitalizing on opportunities that will help us make it possible to continue our growth, extend our impact and increase access to quality care at home.”